Intelligent Ultrasound's AI technology launches on new GE HealthCare ultrasound machines
() , an ultrasound AI software and simulation company, announced that GE HealthCare's SonoLyst software has been launched on GE's new Voluson Signature Series portfolio of ultrasound machines, the Signature 20 and Signature 18. SonoLyst is powered by Intelligent Ultrasound's ScanNav AI imaging technology.
SonoLystlive enhances ultrasound image recognition by automatically capturing images in real-time, as the clinician scans a mid-trimester patient. Intelligent Ultrasound's AI software automatically recognises the anatomy, captures the image and checks it off the list of required views. This eliminates the need to manually freeze, annotate and store images, reducing keystrokes by up to 65% and exam time by up to 40% for sonographers.
SonoLystlive will be offered as a standard feature on the Voluson Signature 20 and as an option on the Voluson Signature 18.
View from Vox
GE HealthCare's SonoLyst software, powered by 's ScanNav AI, has been incorporated into GE's new Voluson Signature line of ultrasound machines. It will be a standard feature on Signature 20 and an option on Signature 18. With the launch, SonoLyst is now available on GE HealthCare's three ultrasound ranges - Expert, Signature, and SWIFT. 's AI technology significantly reduces scanning times, saving time and money for GE Healthcare's customers.
This marks another milestone in 's growing partnership with industry giant GE HealthCare, building on the existing agreement that incorporates ScanNav AI as an option add-on in the SonoLyst software for the Voluson SWIFT and a standard feature on the Voluson Expert 22 and 20. For each ultrasound machine sold by GE that uses ScanNav AI, receives a royalty payment. With the AI technology's growing adoption as a standard feature across the GE range, will see higher recurring revenues.
Intelligent Ultrasound is set to benefit from the rapid growth of the medical imaging AI market, projected to grow at a CAGR of 34.7% between 2022 and 2029. As and GE HealthCare's relationship develops with new software products, there is significant upside going forward. The partnership is one of 's key growth drivers as sales soared 46.9% in FY21 and 33% in FY22. Cavendish predicted 41.4% growth in FY24, with reaching profitability by end of FY24.
Follow News & Updates from Intelligent Ultrasound:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.